Sanofi Consumer Healthcare India financials

·Pharma & HealthChart ›
Latest results Q2 FY27 · Jul–Sep 2026
Revenue
₹263cr+12.5% on Q2 FY26
Net profit
₹76.6cr+21.8% on Q2 FY26
EBITDA margin
38.7%+2.3 pts on Q2 FY26
EPS
₹33.26+21.8% on Q2 FY26

Quarterly results

Every quarter ›
₹ croreQ2 FY27Q2 FY26Change
Revenue263234+12.5%
EBITDA10285.0+19.6%
EBITDA margin38.7%36.3%+2.3 pts
Profit before tax10384.1+22.1%
Net profit76.662.9+21.8%
EPS₹33.26₹27.31+21.8%

Over time

Q2 FY27 · Jul–Sep 2026latest
Revenue₹263 crNet profit₹76.6 crNet margin29.1%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Dec 2025FY25Dec 2024
7,642——
375375327
7,268——
979878725
—+21.2%—
370309271
37.8%35.2%37.4%
357297266
280240181
28.6%27.3%25.0%
₹121.61₹104.39₹78.70
—+32.7%—
—277439
—−7.6−9.9
270270429
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

SANOFICONR₹3,322.80

Sanofi Consumer Healthcare India Limited

· Pharma & Health
₹ CrorePeersPGHLSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCASTRAZENMcap ₹7,642 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY25
31/12/2024
FY26
31/12/2025
Current/LTM
TTM · last close
Market Capitalization——7,642.4
- Cash, Equiv & ST Investments326.9374.8374.8
Enterprise Value——7,267.6
Revenue724.5878.4979.0
Growth %, YoY—+21.2—
EBITDA270.6309.0369.6
Margin %37.3535.1837.75
EBIT266.1297.3356.6
Net Income181.0240.1279.7
Margin %24.9827.3328.57
EPS, Adj (current shares)78.70104.39121.61
Growth %, YoY—+32.7—
Cash from Operations439.0277.4—
Capital Expenditures-9.9-7.6—
Free Cash Flow429.1269.8269.8
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Sanofi Consumer Healthcare India financials and key ratios

Prices at the 29 October 2026 close · figures from the company's filings with NSE

Sanofi Consumer Healthcare India (NSE: SANOFICONR) had a market capitalisation of ₹7,976 crore at the 29 October 2026 close (₹3,468.00 a share), a PE ratio of 28.5 on the last four quarters' profit and a price-to-book ratio of 22.93. In the year to December 2025 its consolidated net profit was ₹240 crore on revenue of ₹878 crore; in Q2 FY27 (July–September 2026) it was ₹76.6 crore, up 21.8% year on year. It had no borrowings on 30 June 2026. Promoters held 71.27% of the shares on 30 September 2026.

Share price used
₹3,468.00 · 29 October 2026 close
Latest balance sheet
30 June 2026
Shareholding pattern
30 September 2026

Sanofi Consumer Healthcare India at a glance · consolidated

Market cap
₹7,976 Crat ₹3,468.00 · 29 Oct close
PE ratio (last 4 quarters)
28.533.2 on the year to December 2025 profit
Price to book (PB)
22.93book value ₹151.26 a share
ROE (the year to December 2025)
73.1%ROCE 82.7%
Debt to equity
0.00net cash ₹491 Cr
Promoter holding
71.27%unchanged vs 30 Jun 202630 September 2026
Dividend yield
2.16%₹75 a share in 12 months
Net worth
₹348 Cr+35.4% vs 30 Jun 202530 June 2026
Free cash flow (the year to December 2025)
₹270 Cr−37.1% vs the year to December 2024

Questions

What is the Sanofi Consumer Healthcare India PE ratio today?

Sanofi Consumer Healthcare India's PE ratio is 28.5 at the 29 October 2026 close (₹3,468.00 a share): a market capitalisation of ₹7,976 crore divided by consolidated net profit of ₹280 crore over the last four quarters (Q3 FY26 to Q2 FY27). On the year to December 2025 net profit (₹240 crore) it is 33.2.

What is the Sanofi Consumer Healthcare India PB ratio (price to book value)?

Sanofi Consumer Healthcare India's price-to-book (PB) ratio is 22.93 at the 29 October 2026 close: a market capitalisation of ₹7,976 crore divided by shareholders' equity (book value) of ₹348 crore on 30 June 2026. That is a book value of ₹151.26 per share against a share price of ₹3,468.00.

What is the Sanofi Consumer Healthcare India net worth?

Sanofi Consumer Healthcare India's net worth — shareholders' equity in its consolidated balance sheet — was ₹348 crore on 30 June 2026, up 35.4% from ₹257 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹7,976 crore at the 29 October 2026 close.

What is the Sanofi Consumer Healthcare India market cap?

Sanofi Consumer Healthcare India's market capitalisation was ₹7,976 crore at the 29 October 2026 close: 2.3 crore shares at ₹3,468.00 each.

Is Sanofi Consumer Healthcare India debt free?

Yes. Sanofi Consumer Healthcare India had no borrowings on 30 June 2026 (consolidated balance sheet), and it held ₹491 crore of cash, bank balances and current investments.

What is the Sanofi Consumer Healthcare India debt to equity ratio?

Sanofi Consumer Healthcare India's debt-to-equity ratio was 0.00 on 30 June 2026: no borrowings against total equity of ₹348 crore. A year earlier, on 30 June 2025, it was 0.00.

What is the Sanofi Consumer Healthcare India ROE and ROCE?

In the year to December 2025, Sanofi Consumer Healthcare India's return on equity (ROE) was 73.1% and its return on capital employed (ROCE) was 82.7%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities).

What is the Sanofi Consumer Healthcare India shareholding pattern?

On 30 September 2026, Sanofi Consumer Healthcare India's shares were held by promoters 71.27%, foreign portfolio investors (FII/FPI) 2.48%, domestic institutions (DII) 18.03% (including mutual funds at 12.92%) and retail and other non-institutional investors 8.22%. Over the year, FII holding was down 0.46 percentage points from 2.94% and DII holding was up 0.82 percentage points from 17.21%.

What is the Sanofi Consumer Healthcare India free cash flow?

In the year to December 2025, Sanofi Consumer Healthcare India generated ₹277 crore of cash from operations and spent ₹7.6 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹270 crore. In the year to December 2024 it was ₹429 crore.

What is the Sanofi Consumer Healthcare India book value per share?

Sanofi Consumer Healthcare India's book value per share was ₹151.26 on 30 June 2026: shareholders' equity of ₹348 crore divided by the 2.3 crore shares in issue, up 35.4% from ₹111.74 a year earlier. The share price at the 29 October 2026 close was ₹3,468.00.

What is the Sanofi Consumer Healthcare India EPS?

Sanofi Consumer Healthcare India's basic earnings per share (EPS) were ₹104.27 in the year to December 2025, against ₹78.59 in the year to December 2024. Over the last four quarters (Q3 FY26 to Q2 FY27) they add up to ₹121.44.

What is the Sanofi Consumer Healthcare India dividend yield?

Sanofi Consumer Healthcare India's dividend yield is 2.16% at the 29 October 2026 close: dividends of ₹75 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹3,468.00. They were ₹75 on 19 June 2026.

What is the Sanofi Consumer Healthcare India dividend in 2026 and its record date?

In 2026, Sanofi Consumer Healthcare India has declared one dividend: ₹75 with record date 19 June 2026.

What is the Sanofi Consumer Healthcare India promoter holding?

Promoters held 71.27% of Sanofi Consumer Healthcare India on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.

What are the Sanofi Consumer Healthcare India latest quarterly results?

Sanofi Consumer Healthcare India's latest results are for Q2 FY27 (July–September 2026), filed on 28 October 2026: consolidated net profit ₹76.6 crore, up 21.8% from ₹62.9 crore in Q2 FY26; revenue from operations ₹263 crore, up 12.5% year on year.

What is the Sanofi Consumer Healthcare India revenue and profit in the year to December 2025?

In the year to December 2025 (January 2024–December 2025), Sanofi Consumer Healthcare India's consolidated net profit was ₹240 crore, up 32.7% from ₹181 crore in the year to December 2024, on revenue from operations of ₹878 crore (up 21.2%).

When are the Sanofi Consumer Healthcare India next results?

Sanofi Consumer Healthcare India has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.

Where do these Sanofi Consumer Healthcare India figures come from?

From Sanofi Consumer Healthcare India's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.